Zydus Lifesciences Ltd.

View in App
519.40 +6.05 ▲1.2%

02 June 2023, 04:01:00 PM
Volume: 27,554

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.zyduscadila.com
Market Cap 52,487.85 Cr.
Enterprise Value(EV) 53,077.95 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 19.37 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) 26.82 Trailing Twelve Months Ending 2023-03
Industry PE 33.43 Trailing Twelve Months Ending 2023-03
Book Value / Share 173.05 Trailing Twelve Months Ending 2023-03
Price to Book Value 3.00 Calculated using Price: 519.40
Dividend Yield 1.16 Period Ending 2022-03
No. of Shares Subscribed 101.22 Cr. 1,012,204,139 Shares
FaceValue 1
About Zydus Lifesciences Ltd.
The company is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value chain of innovating (research & development), manufacturing, marketing and selling of finished dosage human formulations (generics, branded generics and specialty formulations, including biosimilars and vaccines), active pharmaceutical ingredients (APIs), animal healthcare products and consumer wellness products. Innovation is the backbone of the company as it ensures business sustainability through continuous availability of new products for various businesses.

Zydus Lifesciences Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Zydus Lifesciences Ltd. Performance

View details >>
1 Day
+1.18%
1 Week
+2.28%
1 Month
+0.58%
3 Month
+11.36%
6 Month
+24.99%
1 Year
+42.32%
2 Year
-17.25%
5 Year
+46.81%
10 Year
+235.59%

Zydus Lifesciences Ltd. Fundamental Ratios

View details >>
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 26.20 30.85 38.62 23.47 22.50 19.36 11.32 18.88 15.51
Return on Capital Employed (%) 17.67 23.21 28.60 16.52 18.55 15.89 10.02 14.38 15.30
Return on Assets (%) 10.89 13.93 20.14 12.20 11.23 9.34 5.18 9.66 9.40

Zydus Lifesciences Ltd. Balance Sheet

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03* Rs. Cr.
Shh. Funds 3,439 4,252 5,699 6,960 8,745 10,386 10,376 12,992 17,000 17,516
Non Curr. Liab. 1,589 1,342 736 1,903 2,122 3,491 2,854 19 -194 -725
Curr. Liab. 2,814 3,285 3,461 5,306 6,072 7,343 8,269 7,861 7,827 5,531
Minority Int. 144 169 136 156 191 1,293 1,335 1,937 2,054 2,173
Equity & Liab. 7,987 9,047 10,032 14,325 17,141 22,513 22,834 22,810 26,700 24,494
Non Curr. Assets 4,549 4,820 5,752 8,303 8,911 14,015 14,118 14,094 14,438 14,478
Curr. Assets 3,438 4,227 4,280 6,022 8,201 8,498 8,715 8,716 12,095 10,016
Misc. Exp. not W/O
Total Assets 7,987 9,047 10,032 14,325 17,141 22,513 22,834 22,810 26,700 24,494

Zydus Lifesciences Ltd. Profit and Loss

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. TTM
Net Sales 7,224 8,651 9,427 9,377 11,905 13,166 14,253 14,404 15,265 17,580
Other Income 86 57 117 147 133 209 117 75 235 187
Total Income 7,310 8,709 9,543 9,524 12,038 13,374 14,370 14,479 15,501 17,767
Total Expenditure -6,031 -6,897 -7,097 -7,472 -9,058 -10,187 -11,473 -11,018 -11,935 -13,720
PBIDT 1,279 1,811 2,446 2,051 2,980 3,187 2,897 3,460 3,565 4,047
Interest -118 -68 -53 -63 -111 -196 -342 -186 -127 -130
Depreciation -201 -287 -292 -373 -539 -599 -697 -670 -713 -723
Taxation -106 -259 -177 -129 -564 -530 -320 -194 -512 -588
Exceptional Items -17 -10 -3 0 -10 -364 -205 113 -604
PAT 836 1,186 1,921 1,486 1,766 1,852 1,176 2,206 2,326 2,002
Minority Interest -33 -38 -30 -29 -35 -50 -28 -51 -131 -132
Share Associate 43 34 63 47 29 47 46 95
Other Related Items 2
Consolidated Net Profit 804 1,151 1,934 1,488 1,776 1,849 1,177 2,134 4,487 1,960
Adjusted EPS 8 11 19 15 17 18 11 21 44 19

Zydus Lifesciences Ltd. Cash Flow

View details >>
Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 603 903 994 1,894 1,312 919 1,282 2,932 3,294 2,104
Cash Fr. Inv. -682 -438 -465 -864 -2,872 -974 -4,239 -1,012 -725 1,154
Cash Fr. Finan. 286 -529 -351 -935 2,316 52 1,885 -1,528 -2,548 -868
Net Change 207 -64 178 95 756 -3 -1,072 391 22 2,390
Cash & Cash Eqvt 677 613 790 837 1,593 1,590 779 1,178 1,087 3,460

Zydus Lifesciences Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%)
Promoter 74.88 74.88 74.88 74.88 74.88 74.88 74.98 74.98 74.98
Public 25.12 25.12 25.12 25.12 25.12 25.12 25.02 25.02 25.02
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Zydus Lifesciences Ltd. Announcements

View details >>
Fri, 02 Jun 2023
Update
Update-USFDA Inspection
Wed, 24 May 2023
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of the Post Results Earnings Call held on May 18 2023
Fri, 19 May 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper cutting with regard to publication of extracts of audited financial results for the quarter / year ended on March 31 2023 in Financial Express on May 19 2023.

Zydus Lifesciences Ltd. Technical Scans

View details >>
Fri, 02 Jun 2023
Close Crossing Last Week High Close Crossing Last Week High
Closing Above Previous High Closing Above Previous High
Close Within 52 Week High Zone Close Within 52 Week High Zone
Close Above Last Week High Close Above Last Week High
S Closing Above Previous High for 2 Days

Zydus Lifesciences Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 239,777.54 999.35 +1.2%
Divi's Laboratories Ltd. 93,340.08 3,539.90 +0.4%
Cipla Ltd. 77,917.34 966.85 +0.3%
Dr. Reddy's Laboratories Ltd. 76,753.53 4,610.45 +1.3%
Apollo Hospitals Enterprise Ltd. 71,422.15 4,957.90 +2.9%
Torrent Pharmaceuticals Ltd. 60,134.99 1,774.00 -0.1%
Mankind Pharma Ltd. 58,728.27 1,466.05 +4.9%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 28.30 999.35 +1.2%
Divi's Laboratories Ltd. Consolidated 2023-03 51.54 3,539.90 +0.4%
Cipla Ltd. Consolidated 2023-03 27.85 966.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 17.03 4,610.45 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 87.03 4,957.90 +2.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 48.23 1,774.00 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 43.99 1,466.05 +4.9%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 4.28 999.35 +1.2%
Divi's Laboratories Ltd. Consolidated 2023-03 7.36 3,539.90 +0.4%
Cipla Ltd. Consolidated 2023-03 3.33 966.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 3.30 4,610.45 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 11.52 4,957.90 +2.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9.69 1,774.00 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 5.65 1,466.05 +4.9%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 999.35 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,539.90 +0.4%
Cipla Ltd. Consolidated 2022-03 0.04 966.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,610.45 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,957.90 +2.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,774.00 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 0.14 1,466.05 +4.9%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 999.35 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,539.90 +0.4%
Cipla Ltd. Consolidated 2022-03 13.10 966.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,610.45 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,957.90 +2.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,774.00 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,466.05 +4.9%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 999.35 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,539.90 +0.4%
Cipla Ltd. Consolidated 2022-03 13.10 966.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,610.45 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,957.90 +2.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,774.00 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,466.05 +4.9%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 999.35 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,539.90 +0.4%
Cipla Ltd. Consolidated 2022-03 21,763.34 966.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,610.45 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,957.90 +2.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,774.00 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 7,781.56 1,466.05 +4.9%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 999.35 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,539.90 +0.4%
Cipla Ltd. Consolidated 2022-03 2,559.47 966.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,610.45 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,957.90 +2.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,774.00 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 1,452.96 1,466.05 +4.9%

Zydus Lifesciences Ltd. FAQ's

What is Zydus Lifesciences share price?
Can I buy Zydus Lifesciences shares now?
What is the Dividend Yield of Zydus Lifesciences?
What is the Market Cap of Zydus Lifesciences?
What are the key metrics to analyse Zydus Lifesciences?
What is the 52 Week High and Low of Zydus Lifesciences?
What is the trend of Zydus Lifesciences share price?